SCHEMBL25035885

SCHEMBL25035885

c1ccc(-c2nc(-c3ccccc3)nc(-c3cccc(-c4cccc(-c5cccc6c5C5(c7c-6ccc6ccccc76)C6CC7CC(C6)CC5C7)c4)c3)n2)cc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
KDM4E B2RXH2 1/20 0.34
ALDH1A1 P00352 1/20 0.34
TP53 P04637 1/20 0.34
HPGD P15428 1/20 0.34
TSHR P16473 1/20 0.34
NFKB1 P19838 1/20 0.34
MAPK1 P28482 1/20 0.34
NFKB2 Q00653 1/20 0.34
RELA Q04206 1/20 0.34
ATM Q13315 1/20 0.34
HSD17B10 Q99714 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
HTT P42858 1/20 0.33
GP6 Q9HCN6 1/20 0.32
NPC1 O15118 1/20 0.31
LMNA P02545 1/20 0.31
RECQL P46063 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25037703 0.96 PDE7A (0.33) MAPTSMN1; SMN2KDM4EALDH1A1TP53
SCHEMBL25035880 0.93 PDE7A (0.34) MAPTSMN1; SMN2KDM4EALDH1A1TP53
SCHEMBL25035791 0.92 NT5E (0.35)
SCHEMBL25038404 0.91 HSD17B1 (0.34) MAPTSMN1; SMN2KDM4EALDH1A1TP53
SCHEMBL25038156 0.88 PDE7A (0.33) MAPTSMN1; SMN2KDM4EALDH1A1TP53
SCHEMBL25038216 0.88 MEN1 (0.39) MAPTKDM4EALDH1A1TP53HPGD
SCHEMBL25035883 0.88 GP6 (0.33) MAPTSMN1; SMN2KDM4EALDH1A1TP53
SCHEMBL25038019 0.87 GP6 (0.35) MAPTSMN1; SMN2KDM4EALDH1A1TP53
SCHEMBL25035795 0.87 GP6 (0.35) MAPTSMN1; SMN2KDM4EALDH1A1TP53
SCHEMBL25037893 0.86 KDM4E (0.32) MAPTSMN1; SMN2KDM4EALDH1A1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11691952-B2 Nitrogen-containing compound, and electronic element and electronic device using same SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-07-04 US disclosed
US-11691952-B2 Nitrogen-containing compound, and electronic element and electronic device using same SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-07-04 US disclosed
US-20230052660-A1 NITROGEN-CONTAINING COMPOUND, AND ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-02-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230052660-A1 NITROGEN-CONTAINING COMPOUND, AND ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME NOD1, NFE2L2, NOTCH1 MAPT 4502/4885SMN1; SMN2 4415/4885KDM4E 837/4885
US-11691952-B2 Nitrogen-containing compound, and electronic element and electronic device using same NOD1, NFE2L2, NOTCH1 MAPT 4502/4885SMN1; SMN2 4415/4885KDM4E 837/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.